Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07237451
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:58.222954+00:00
Published At
2025-11-19T00:00:00+00:00
Record Updated At
2025-11-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["CKD - Chronic Kidney Disease", "Heart Failure Preserved Ejection Fraction", "SGLT2 Inhibitors", "Diabetes (DM)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-19"
protocolSection.identificationModule.nctId
"NCT07237451"
protocolSection.identificationModule.officialTitle
"Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • CKD - Chronic Kidney Disease (protocolSection.conditionsModule.conditions)
  • Heart Failure Preserved Ejection Fraction (protocolSection.conditionsModule.conditions)
  • SGLT2 Inhibitors (protocolSection.conditionsModule.conditions)
  • Diabetes (DM) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.